Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EBIT (2018 - 2025)

AdaptHealth (AHCO) has 8 years of EBIT data on record, last reported at -$73.3 million in Q4 2025.

  • For Q4 2025, EBIT fell 175.03% year-over-year to -$73.3 million; the TTM value through Dec 2025 reached $90.9 million, down 65.54%, while the annual FY2025 figure was $90.9 million, 65.54% down from the prior year.
  • EBIT reached -$73.3 million in Q4 2025 per AHCO's latest filing, down from $61.7 million in the prior quarter.
  • Across five years, EBIT topped out at $97.7 million in Q4 2024 and bottomed at -$461.0 million in Q3 2023.
  • Average EBIT over 5 years is $8.6 million, with a median of $52.5 million recorded in 2022.
  • Peak YoY movement for EBIT: surged 471.01% in 2021, then plummeted 970.72% in 2023.
  • A 5-year view of EBIT shows it stood at $69.1 million in 2021, then tumbled by 61.3% to $26.7 million in 2022, then plummeted by 914.77% to -$217.8 million in 2023, then soared by 144.84% to $97.7 million in 2024, then tumbled by 175.03% to -$73.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$73.3 million in Q4 2025, $61.7 million in Q3 2025, and $79.3 million in Q2 2025.